NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 76 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $330 | -98.1% | 384 | -97.7% | 0.00% | – |
| Q3 2023 | $17,755 | -88.9% | 16,593 | -73.1% | 0.00% | -100.0% |
| Q2 2023 | $159,588 | +19.1% | 61,617 | +87.6% | 0.00% | 0.0% |
| Q1 2023 | $133,979 | -28.3% | 32,838 | -11.7% | 0.00% | 0.0% |
| Q4 2022 | $186,774 | -76.0% | 37,206 | -5.7% | 0.00% | -90.9% |
| Q2 2020 | $779,000 | – | 39,472 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|